You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

METOLAZONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Metolazone patents expire, and when can generic versions of Metolazone launch?

Metolazone is a drug marketed by Alembic, Ani Pharms, Bayshore Pharms Llc, Innogenix, Mylan, Ne Rx Pharma, Renata, Roxane, Rubicon, Sandoz, and Watson Labs. and is included in twelve NDAs.

The generic ingredient in METOLAZONE is metolazone. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the metolazone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Metolazone

A generic version of METOLAZONE was approved as metolazone by SANDOZ on December 19th, 2003.

  Try a Trial

Drug patent expirations by year for METOLAZONE
Drug Prices for METOLAZONE

See drug prices for METOLAZONE

Drug Sales Revenue Trends for METOLAZONE

See drug sales revenues for METOLAZONE

Recent Clinical Trials for METOLAZONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rambam Health Care CampusPhase 4
St George's, University of LondonPhase 3
NHS Greater Glasgow and ClydePhase 3

See all METOLAZONE clinical trials

Pharmacology for METOLAZONE
Drug ClassThiazide-like Diuretic
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for METOLAZONE
Anatomical Therapeutic Chemical (ATC) Classes for METOLAZONE

US Patents and Regulatory Information for METOLAZONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz METOLAZONE metolazone TABLET;ORAL 076466-002 Dec 19, 2003 AB RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs METOLAZONE metolazone TABLET;ORAL 076891-001 Jul 21, 2004 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Alembic METOLAZONE metolazone TABLET;ORAL 213251-001 Dec 2, 2020 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ne Rx Pharma METOLAZONE metolazone TABLET;ORAL 216216-003 Oct 25, 2022 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Rubicon METOLAZONE metolazone TABLET;ORAL 215184-002 Aug 20, 2021 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Bayshore Pharms Llc METOLAZONE metolazone TABLET;ORAL 214799-001 Mar 30, 2021 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ani Pharms METOLAZONE metolazone TABLET;ORAL 075543-001 Jan 6, 2004 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.